Merit Financial Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45M Sell
6,283
-124
-2% -$52.4K 0.02% 666
2026
Q1
$3.03M Sell
6,407
-51
-0.8% -$25.7K 0.02% 538
2025
Q4
$3.02M Buy
6,458
+1,570
+32% +$729K 0.02% 502
2025
Q3
$2.08M Buy
4,888
+214
+5% +$82.9K 0.02% 561
2025
Q2
$1.79M Buy
4,674
+1,381
+42% +$498K 0.02% 566
2025
Q1
$1.14M Buy
3,293
+1,724
+110% +$554K 0.02% 607
2024
Q4
$471K Buy
1,569
+909
+138% +$318K 0.01% 745
2024
Q3
$268K Sell
660
-594
-47% -$217K 0.01% 700
2024
Q2
$403K Sell
1,254
-12
-0.9% -$3.9K 0.01% 636
2024
Q1
$390K Buy
1,266
+85
+7% +$26K 0.01% 619
2023
Q4
$320K Sell
1,181
-125
-10% -$30.9K 0.01% 605
2023
Q3
$321K Sell
1,306
-71
-5% -$19.4K 0.01% 571
2023
Q2
$418K Buy
1,377
+71
+5% +$19.7K 0.01% 506
2023
Q1
$344K Buy
1,306
+130
+11% +$33K 0.01% 479
2022
Q4
$282K Buy
+1,176
New +$263K 0.01% 552

Other funds holding HCA

Merit Financial Group's HCA Position: Q2 2026 in Review

Merit Financial Group reduced its HCA Healthcare (HCA) stake by 1.9% in Q2 2026, selling an estimated $52.4K and leaving 6,283 shares worth $2.45M. The position accounts for 0.02% of the portfolio, ranked #666.

Merit Financial Group first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.03M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Merit Financial Group held 6,283 shares of HCA Healthcare worth $2.45M as of Q2 2026.
  • Merit Financial Group sold 124 HCA Healthcare shares in Q2 2026, an estimated $52.4K.
  • HCA Healthcare made up 0.02% of Merit Financial Group's portfolio in Q2 2026, its #666 holding.
  • Merit Financial Group first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Merit Financial Group's HCA Healthcare position peaked at $3.03M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.